Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy

被引：2
|
作者：
Meyer, Ralph M. [1 ,2 ,3 ,4 ]
Hoppe, Richard T. [5 ]
机构：
[1] Queens Univ, NCIC, Clin Trials Grp, Kingston, ON, Canada
[2] Queens Univ, Dept Oncol, Kingston, ON, Canada
[3] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada
[4] Queens Univ, Dept Commun Hlth & Epidemiol, Kingston, ON K7L 3N6, Canada
[5] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
来源：
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM | 2012年
关键词：
INVOLVED-FIELD RADIOTHERAPY; COMBINED-MODALITY TREATMENT; COMBINATION CHEMOTHERAPY; PRACTICE GUIDELINES; MOPP CHEMOTHERAPY; NODE RADIOTHERAPY; CLINICAL-TRIALS; DISEASE; VINBLASTINE; ABVD;
D O I：
10.1182/asheducation-2012.1.313
中图分类号：
G40 [教育学];
学科分类号：
040101 ; 120403 ;
摘要：
The results of recent clinical trials for the management of limited-stage Hodgkin lymphoma have led to considerable debate, especially regarding the role of radiation therapy. This review highlights those recent trials and provides perspectives regarding their interpretation from a radiation oncologist and a hematologist. The trial protocol is available at http://www.nejm.org/doi/suppl/10.1056/NEJMoa1111961/suppl_file/nejmoa1111961_protocol.pdf.
引用
收藏
页码：313 / 321
页数：9
相关论文
共 50 条
  • [41] Radiation for early-stage Hodgkin's disease?: In reply
    Ng, AK
    Weeks, JC
    Mauch, PM
    Kuntz, KM
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) : 943 - 944
  • [42] The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease
    Evens, Andrew M.
    Kostakoglu, Lale
    BLOOD, 2014, 124 (23) : 3356 - 3364
  • [43] Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma
    Eich, Hans Theodor
    Mueller, Rolf-Peter
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 (Suppl 2) : 16 - 18
  • [44] Current Role and Future Developments of Radiotherapy in Early-stage Favourable Hodgkin's Lymphoma
    Hans Theodor Eich
    Rolf-Peter Müller
    Strahlentherapie und Onkologie, 2007, 183 : 16 - 18
  • [45] The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease
    Evens, Andrew M.
    Kostakoglu, Lale
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 135 - 143
  • [46] Role of Radiation Therapy in Early-Stage Diffuse Large B-Cell Lymphoma (DLBCL) in Elderly
    Jhavar, S. G.
    Thawani, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S679 - S679
  • [47] Nivolumab and AVD for Early-Stage Unfavorable Hodgkin Lymphoma (NIVAHL)
    Broeckelmann, Paul J.
    Goergen, Helen
    Keller, Ulrich
    Meissner, Julia
    Ordemann, Rainer
    Halbsguth, Teresa V.
    Sasse, Stephanie
    Soekler, Martin
    Kerkhoff, Andrea
    Mathas, Stephan
    Huttmann, Andreas
    Bormann, Matthias
    Zimmermann, Andreas
    Fuchs, Michael
    von Tresckow, Bastian
    Baues, Christian
    Rosenwald, Andreas
    Klapper, Wolfram
    Kobe, Carsten
    Borchmann, Peter
    Engert, Andreas
    BLOOD, 2019, 134
  • [48] Current developments in the treatment of early-stage classical Hodgkin lymphoma
    Borchmann, Sven
    von Tresckow, Bastian
    Engert, Andreas
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (05) : 377 - 383
  • [49] Balancing risk and benefit in early-stage classical Hodgkin lymphoma
    Broeckelmann, Paul J.
    Sasse, Stephanie
    Engert, Andreas
    BLOOD, 2018, 131 (15) : 1666 - 1678
  • [50] Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma
    Koerholz, Dieter
    Mauz-Koerholz, Christine
    Wallace, W. Hamish
    Landman-Parker, Judith
    Kluge, Regine
    Hasenclever, Dirk
    LANCET ONCOLOGY, 2023, 24 (06): : E231 - E231
12345